| Code | 3378C | ||||||||||
| MA number | 09/0083/17-S | ||||||||||
| Product Form: | plv ino 50x40 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.03.2017 |
| Validity: | 29.03.2022 |
| MA renewed: | Renewal application submitted |
| Pediatric posology: | Yes |
| SPC: |
SPC_Pantoprazol Accord 40 mg prášok na injekčný roztok_01_2020.doc
|
| PIL: |
PIL_Pantoprazol Accord 40 mg prášok na injekčný roztok_01_2020.doc
|
| Safety feature | Yes |
| Data update: | 20.04.2018 |
